Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy.
OBJECTIVE
The aim was to evaluate direct health care costs of central line-associated bloodstream infections (CLABSI) and to calculate the cost-effectiveness ratio of closed fully collapsible plastic intravenous infusion containers vs. open (glass) infusion containers.


METHODS
A two-year, prospective case-control study was undertaken in four intensive care units in an Italian teaching hospital. Patients with CLABSI (cases) and patients without CLABSI (controls) were matched for admission departments, gender, age, and average severity of illness score. Costs were estimated according to micro-costing approach. In the cost effectiveness analysis, the cost component was assessed as the difference between production costs while effectiveness was measured by CLABSI rate (number of CLABSI per 1000 central line days) associated with the two infusion containers.


RESULTS
A total of 43 cases of CLABSI were compared with 97 matched controls. The mean age of cases and controls was 62.1 and 66.6 years, respectively (p = 0.143); 56% of the cases and 57% of the controls were females (p = 0.922). The mean length of stay of cases and controls was 17.41 and 8.55 days, respectively (p < 0.001). Overall, the mean total costs of patients with and without CLABSI were euro 18,241 and euro 9,087, respectively (p < 0.001). On average, the extra cost for drugs was euro 843 (p < 0.001), for supplies euro 133 (p = 0.116), for lab tests euro 171 (p < 0.001), and for specialist visits euro 15 (p = 0.019). The mean extra cost for hospital stay (overhead) was euro 7,180 (p < 0.001). The closed infusion container was a dominant strategy. It resulted in lower CLABSI rates (3.5 vs. 8.2 CLABSIs per 1000 central line days for closed vs. open infusion container) without any significant difference in total production costs. The higher acquisition cost of the closed infusion container was offset by savings incurred in other phases of production, especially waste management.


CONCLUSIONS
CLABSI results in considerable and significant increase in utilization of hospital resources. Use of innovative technologies such as closed infusion containers can significantly reduce the incidence of healthcare acquired infection without posing additional burden on hospital budgets.
Tarricone
Rosanna
R
CERGAS-Bocconi University, Via Roentgen 1, 21036 Milan, Italy. aleksandra.torbica@unibocconi.it.
Torbica
Aleksandra
A
Franzetti
Fabio
F
Rosenthal
Victor D
VD
Infect Control Hosp Epidemiol. 2002 Apr;23(4):190-7
12002233
Hosp Formul. 1993 Jan;28 Suppl 1:51-4
10123840
J Hosp Infect. 2004 Feb;56(2):142-9
15019227
Minerva Anestesiol. 2004 May;70(5):329-37
15181413
Infect Control Hosp Epidemiol. 2006 Dec;27(12):1291-8
17152025
N Engl J Med. 2003 Mar 20;348(12):1123-33
12646670
J Hosp Infect. 2007 Jun;65 Suppl 2:3-9
17540232
Crit Care Med. 2006 Aug;34(8):2084-9
16763511
J Formos Med Assoc. 2005 May;104(5):318-26
15959598
JAMA. 1994 May 25;271(20):1598-601
8182812
J Hosp Infect. 2007 Jun;65 Suppl 2:30-3
17540238
J Chemother. 1995 Jul;7 Suppl 3:55-66
8609539
Ann Intern Med. 2000 Mar 7;132(5):391-402
10691590
Arch Surg. 2001 Feb;136(2):229-34
11177147
J Hosp Infect. 2001 Mar;47(3):198-209
11247680
J Health Serv Res Policy. 1999 Oct;4(4):255-6
10623043
Ann Intern Med. 2006 Oct 17;145(8):582-91
17043340
Am J Infect Control. 2003 Dec;31(8):475-80
14647110
Infection. 2003 Dec;31 Suppl 2:35-43
15018471
Am J Infect Control. 2004 May;32(3):135-41
15153924
N Engl J Med. 2003 Feb 13;348(7):651-6
12584377
Clin Infect Dis. 1995 Aug;21(2):403-8
8562751
Am J Infect Control. 2005 Nov;33(9):501-9
16260325
Am J Infect Control. 1991 Feb;19(1):19-35
1850582
J Hosp Infect. 2006 Jun;63(2):124-32
16621137
Epidemiol Infect. 2009 Jul;137(7):1041-8
19144245
BMJ. 1998 Oct 31;317(7167):1195-200
9794854
J Intraven Nurs. 2001 May-Jun;24(3):180-205
11530364
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1027-30
10988125
J Hosp Infect. 1995 Jul;30(3):181-91
8522774
Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90
11401878
Infect Control Hosp Epidemiol. 2007 Mar;28(3):280-92
17326018
Am J Respir Crit Care Med. 1999 Sep;160(3):976-81
10471627
Clin Infect Dis. 1993 Jun;16(6):778-84
8329510